| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/16/2006 | CN1269833C Novel aromatic amides, preparation method and application as medicines |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269527C Compound alliin powder injection |
| 08/16/2006 | CN1269526C Application of agglutinin II protein of rhizome of manyflower solmonaeal in preparation of pharmacy for treating or preventing hepatitis B |
| 08/16/2006 | CN1269525C Application of agglutinin II protein of rhizome of king solomonseal in preparation of medicine for treating or preventing bleb-caused diseases |
| 08/16/2006 | CN1269524C Thymosin augmentation of genetic immunization |
| 08/16/2006 | CN1269523C Combined Chinese traditional medicine for strengthening immunity, anti virus, dispeling the effects of alcohol and preventing influenza and catch cold |
| 08/16/2006 | CN1269518C Compound medicine for treating tuberculosis and its preparing method |
| 08/16/2006 | CN1269517C Acquired immuno-deficiency syndrome resistant oral liquid |
| 08/16/2006 | CN1269507C Medication for detoxifying and nourishing saliva and qi |
| 08/16/2006 | CN1269505C Medicine liquid for curing hepatopathy |
| 08/16/2006 | CN1269503C Chinese patent medicinal pill for curing syphilis and its preparation method |
| 08/16/2006 | CN1269502C Common goldenrod medicine gainst catching cold and its preparation |
| 08/16/2006 | CN1269498C Quality control method of Chinese medicinal composition possessing antipyretic |
| 08/16/2006 | CN1269496C Preparation method of injection for treating hepatitis B |
| 08/16/2006 | CN1269495C Medicinal powder for treating beriberi |
| 08/16/2006 | CN1269491C Isatis root extract composition, its preparation method and application |
| 08/16/2006 | CN1269490C Composition of suppressing infection, and veberage and food contg. same |
| 08/16/2006 | CN1269479C Externally used liquid preparation containing fibrauretine and its application on genital tract, oral cavity and upper respiratory tract |
| 08/16/2006 | CN1269478C Micro-capsules of berberine hydrochloride and their preparations |
| 08/16/2006 | CN1269420C Use of nutritional compositions which contain non-digestible polysaccharides |
| 08/15/2006 | US7091363 5-alkyl-2-thia-5-azabicyclo[2.2.1]heptan-3-ones or salts thereof which are useful as synthetic intermediates |
| 08/15/2006 | US7091356 Tumor necrosis factor, to inhibit phosphodiesterase in a mammal |
| 08/15/2006 | US7091352 Antiinflammatory agents; analgesics; antiarthritic agents |
| 08/15/2006 | US7091343 Compositions useful as inhibitors of protein kinases |
| 08/15/2006 | US7091324 For diagnosis and therapy of HCV infection, including being useful in the identification of patients expected to benefit from certain therapeutic strategies |
| 08/15/2006 | US7091310 Chemokine analogs for the treatment of human disease |
| 08/15/2006 | US7091239 DNA polymerase inhibitors, mikanolide and dihydromikanolide |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091219 Administering an effective amount of bis-sulfonamide hydroxyethyl-amino derivative to a HIV patient to prevent the viral replication |
| 08/15/2006 | US7091217 Chemokine receptor binding heterocyclic compounds |
| 08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
| 08/15/2006 | US7091209 Dihydroxypyridmidine carboxylic acids as viral polymerase inhibitors |
| 08/15/2006 | US7091204 Sulfonamides |
| 08/15/2006 | US7091197 Beta-lactamase inhibitor prodrug |
| 08/15/2006 | US7091196 triazoles and optionally carrier mixtures used for prohylaxis of infections, as antiproliferative agents, fungicides, bactericides, parasiticides, viricides, antiinflammatory agents and/or prokinetic agents (gastrointestinal modulatory) |
| 08/15/2006 | US7091195 Derived from plants; for preventing or inhibiting tumor growth |
| 08/15/2006 | US7091190 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 08/15/2006 | US7091030 Composition for the preservation of viruses |
| 08/15/2006 | US7091022 Mitogen activated kinase |
| 08/15/2006 | US7090981 Chicken anaemia viruses of low pathogenicity |
| 08/15/2006 | US7090854 Chicken anaemia viruses of low pathogenicity |
| 08/15/2006 | US7090846 Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body |
| 08/15/2006 | US7090840 Lactobacillus paracasei subsp. paracasei strain antibacterial against Helicobacter pylori and Escherichia coli 0157:h7 |
| 08/15/2006 | US7090835 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 08/15/2006 | CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity |
| 08/15/2006 | CA2213987C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid |
| 08/15/2006 | CA2211612C [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides |
| 08/15/2006 | CA2190983C New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 08/15/2006 | CA2107439C Phospholipid derivatives containing phosphorous, arsenic, antimony or bismuth |
| 08/10/2006 | WO2006084210A2 Hif modulating compounds and methods of use thereof |
| 08/10/2006 | WO2006084141A2 Suspension formulation of interferon |
| 08/10/2006 | WO2006084056A2 Compounds and methods for modulating communication and virulence in quorum sensing bacteria |
| 08/10/2006 | WO2006084053A1 8-n-substituted-2h-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents |
| 08/10/2006 | WO2006084006A1 Human antibodies against rabies and uses thereof |
| 08/10/2006 | WO2006083687A1 Crystal salt of xanthine oxidase inhibitors |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | WO2006083266A1 Inhibitors of bacterial type iii protein secretion systems |
| 08/10/2006 | WO2006082975A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | WO2006082822A1 Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus |
| 08/10/2006 | WO2006082821A1 Preventive or therapeutic agent for herpesvirus-related disease |
| 08/10/2006 | WO2006082820A1 Therapeutic agent for herpes progenitalis |
| 08/10/2006 | WO2006082435A1 Method and use of interferon compositions for the treatment of avian influenza |
| 08/10/2006 | WO2006082088A1 Ester-linked gemini surfactant compounds for use in gene therapy |
| 08/10/2006 | WO2006081808A1 Pharmaceutical substance for the treatment of multiple sclerosis and aids |
| 08/10/2006 | WO2006081722A1 A purification and cultivation method of ocean sponge pluripotent stem cell |
| 08/10/2006 | WO2006081665A1 Purine nucleoside analogs |
| 08/10/2006 | WO2006069193A3 Imidazo[4,5-c]pyridine compound and method of antiviral treatment |
| 08/10/2006 | WO2006060920A8 Novel uses of egf |
| 08/10/2006 | WO2006047671A3 4-aminotetracyclines and methods of use thereof |
| 08/10/2006 | WO2006046112A3 Ketolide derivatives as antibacterial agents |
| 08/10/2006 | WO2006018807A8 Crystalline forms of cefdinir |
| 08/10/2006 | WO2005123069A3 Gram-positive carbapenem antibacterials and processes for their preparation |
| 08/10/2006 | US20060178399 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| 08/10/2006 | US20060178369 Cinnamic acid amides |
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | US20060178359 Tricyclic compound, process for producing the same, and use |
| 08/10/2006 | US20060178336 Oral administration of therapeutic agent coupled to transporting agent induces tolerance |
| 08/10/2006 | US20060178327 Inhibition of gene expression by delivery of specially selected double stranded or other forms of small interfering RNA precursors enabling the formation and function of small interfering RNA in vivo and in vitro |
| 08/10/2006 | US20060178324 Lipophilic derivatives of double-stranded ribonucleic acid |
| 08/10/2006 | US20060178319 antibiotics; caprazamycin B is subjected to acid-hydrolysis |
| 08/10/2006 | US20060177819 genetic engineered polynucleotides comprising nucleotide sequences that code alphavirus replication recognition sequences, nonstructural proteins and heterologous polynucleotides; infectious, replication-defective alphavirus particles used for immunotherapy, treatment of cancer and gene delivery |
| 08/10/2006 | US20060177528 Formulation Of A Mixture Of Free-B-Ring Flavonoids And Flavans As A Therapeutic Agent |
| 08/10/2006 | US20060177517 Antiinflammtory agent and antiinflammatory medical material |
| 08/10/2006 | US20060177511 Antiseptic compositions and methods |
| 08/10/2006 | US20060177443 Integrin antagonists |
| 08/10/2006 | US20060177432 Methods and reagents for protease inhibition |
| 08/10/2006 | US20060177420 treatment of a tumor by administering to a patient an effective amount of active dendritic cells (DC) that are tumor-specific and secrete IL12 |
| 08/10/2006 | US20060177382 Delivery of antiemetics through an inhalation route |
| 08/10/2006 | DE60024843T2 Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten Containing vaccines for oral use the liposome and a nucleic acid |
| 08/10/2006 | DE102005004752A1 Pharmazeutischer Wirkstoff zur Behandlung von Multipler Sklerose und AIDS A pharmaceutical agent for the treatment of multiple sclerosis and AIDS |
| 08/10/2006 | DE102005004643A1 Antiviral combination useful for prevention and therapy of viral diseases, comprising hyaluronic acid sulfate and/or carboxyalkylated derivatives and natural substance or its extract with antiinflammatory and antiviral characteristics |
| 08/10/2006 | CA2830588A1 Conjugation of streptococcal capsular saccharides |
| 08/10/2006 | CA2596993A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | CA2596851A1 Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus |
| 08/10/2006 | CA2596850A1 Medicament for genital herpes |
| 08/10/2006 | CA2596697A1 Human antibodies against rabies and uses thereof |
| 08/10/2006 | CA2596686A1 Preventive or therapeutic agent for herpesvirus-related disease |
| 08/10/2006 | CA2596480A1 Compounds and methods for modulating communication and virulence in quorum sensing bacteria |
| 08/10/2006 | CA2596368A1 Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase |